v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
May 31, 2025
May 31, 2024
Current Assets    
Cash and cash equivalents $ 55,893 $ 76,056
Accounts receivable, net of allowances of $2,215 and $2,141 respectively 42,890 43,610
Inventories 62,006 60,616
Prepaid expenses and other 7,535 12,971
Total current assets 168,324 193,253
Property, plant and equipment, Net 32,300 35,666
Intangible assets, net 69,116 77,383
Other assets 10,404 11,369
Total Assets 280,144 317,671
Current Liabilities    
Accounts payable 33,291 37,751
Accrued liabilities 35,518 41,098
Current portion of contingent consideration 0 4,728
Other current liabilities 7,388 7,578
Total current liabilities 76,197 91,155
Deferred income taxes 4,073 4,852
Other long-term liabilities 16,904 16,078
Total Liabilities 97,174 112,085
Commitments and Contingencies (Note 17)
Stockholders’ Equity    
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 41,607,877 and 40,801,597 shares issued and 40,994,030 and 40,431,597 shares outstanding at May 31, 2025 and 2024, respectively 385 385
Additional paid-in capital 621,186 610,484
Accumulated deficit (429,197) (395,204)
Treasury stock, 613,847 and 370,000 shares, at cost at May 31, 2025 and 2024, respectively (7,381) (5,714)
Accumulated other comprehensive loss (2,023) (4,365)
Total Stockholders' Equity 182,970 205,586
Total Liabilities and Stockholders' Equity $ 280,144 $ 317,671